PXN and cancer: Our studies here show that MLCK210 also play a key role in activating integrin α4β1 by promoting myosin-dependent Rap1 activation and localization and subsequent Talin and Paxillin binding to the integrin cytoplasmic tail, thereby contributing to cancer progression.